Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trialMichel Bazinet, Andrew Vaillant, Valentin Cebotarescu et al.|The Lancet. Gastroenterology & hepatology|2017Cited by 249
Akt-mediated Liver Growth Promotes Induction of Cyclin E through a Novel Translational Mechanism and a p21-mediated Cell Cycle ArrestLisa K. Mullany, Jeffrey H. Albrecht|Journal of Biological Chemistry|2007Cited by 56
Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidationSushama Kamarajugadda, Jeffrey H. Albrecht|Oncotarget|2016Cited by 29
Cyclin D1 extensively reprograms metabolism to support biosynthetic pathways in hepatocytesHeng Wu, Jeffrey H. Albrecht|Journal of Biological Chemistry|2023Cited by 7